全球无针给药装置市场规模、份额、趋势和成长分析报告（2026-2034年）

无针给药装置的市场规模预计将从 2025 年的 215.2 亿美元成长到 2034 年的 434.5 亿美元，2026 年至 2034 年的复合年增长率为 8.12%。

由于人们越来越关注针刺伤和传统注射带来的不适，全球无针给药装置市场正经历显着成长。包括喷射注射器和经皮吸收贴片在内的无针技术，为疫苗接种和慢性病管理提供了更安全、更方便的替代方案。疫苗接种计划的扩展以及人们对微创手术日益增长的偏好，进一步推动了市场成长。

关键成长要素包括药物传递系统的技术进步以及糖尿病等慢性疾病盛行率的上升。患者依从性的提高和交叉感染风险的降低增强了这些设备的吸引力。政府推广疫苗接种的措施以及生物製药和自我给药疗法的进步也促进了全球需求的成长。

未来前景依然光明，主要得益于生物製药和大分子药物应用拓展研究的不断深入。与穿戴式科技和智慧给药系统的融合可望进一步提升用药便利性。儘管高成本和监管方面的挑战可能构成一定障碍，但持续的技术创新有望推动市场普及，并支撑其长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球无针给药装置市场：依技术划分

• 市场分析、洞察与预测
• 吸入器技术
• 经皮吸收贴片技术
• 一种新型无针技术

第五章：全球无针给药装置市场：依应用划分

• 市场分析、洞察与预测
• 疫苗接种
• 疼痛管理
• 用于糖尿病治疗的胰岛素给药系统
• 儿童注射
• 其他的

第六章：全球无针给药装置市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • PenJet
  • Zealand Pharma
  • UCB SA
  • PharmaJet
  • 3M
  • Verdict Media Limited
  • INJEX Pharma AG
  • Antares Pharma
  • Endo Pharmaceuticals Inc
  • Bioject Medical TechnologiesInc
  • Crossject SA

The Needle-Free Drug Delivery Devices Market size is expected to reach USD 43.45 Billion in 2034 from USD 21.52 Billion (2025) growing at a CAGR of 8.12% during 2026-2034.

The Global Needle-Free Drug Delivery Devices Market has grown significantly due to increasing concerns over needle-stick injuries and patient discomfort associated with traditional injections. Needle-free technologies, including jet injectors and transdermal patches, provide safer and more convenient alternatives for vaccine administration and chronic disease management. Rising vaccination programs and growing preference for minimally invasive procedures have further fueled market expansion.

Major growth drivers include technological advancements in drug delivery systems and the rising prevalence of chronic diseases such as diabetes. Improved patient compliance and reduced risk of cross-contamination enhance the appeal of these devices. Government initiatives promoting immunization and advancements in biologics and self-administration therapies also contribute to increasing demand globally.

Future prospects remain promising as research focuses on expanding applications for biologics and large-molecule drugs. Integration with wearable and smart drug delivery systems may further enhance usability. While high device costs and regulatory challenges may pose barriers, continuous innovation is expected to strengthen adoption and support long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Inhaler Technology
• Transdermal Patch Technology
• Novel Needle-Free Technologies

By Application

• Vaccine Delivery
• Pain Management
• Insulin Delivery for Diabetes
• Pediatric Injections
• Others

COMPANIES PROFILED

• PenJet, Zealand Pharma, UCB SA, PharmaJet, 3M, Verdict Media Limited, INJEX Pharma AG, Antares Pharma, Endo Pharmaceuticals Inc, Bioject Medical Technologies, Inc, Crossject SA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Inhaler Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transdermal Patch Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Novel Needle-Free Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccine Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Insulin Delivery for Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pediatric Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 PenJet
  • 8.2.2 Zealand Pharma
  • 8.2.3 UCB S.A
  • 8.2.4 PharmaJet
  • 8.2.5 3M
  • 8.2.6 Verdict Media Limited
  • 8.2.7 INJEX Pharma AG
  • 8.2.8 Antares Pharma
  • 8.2.9 Endo Pharmaceuticals Inc
  • 8.2.10 Bioject Medical TechnologiesInc
  • 8.2.11 Crossject SA